King Drug Co. of Florence v. Abbott Labs.

Full title: KING DRUG CO. OF FLORENCE, INC., et al. v. ABBOTT LABORATORIES, et al.

Court: United States District Court, E.D. Pennsylvania

Date published: Mar 23, 2022

Civil Action 19-3565 (E.D. Pa. Mar. 23, 2022)

Opinion

Civil Action 19-3565

03-23-2022

KING DRUG CO. OF FLORENCE, INC., et al. v. ABBOTT LABORATORIES, et al.

Harvey Bartle III, J.

ORDER

Harvey Bartle III, J.

AND NOW, this 23rd day of March 2022, for the reasons set forth in the foregoing memorandum, it is hereby ORDERED that the motion of plaintiffs to preclude defendants AbbVie and Besins from relitigating facts and issues decided in FTC v. AbbVie Inc. (Doc. #156) is DENIED.